INKT
Income statement / Annual
Last year (2023), MiNK Therapeutics, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, MiNK Therapeutics, Inc.'s net income was -$22.46 M.
See MiNK Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$2.70 B
|
$0.00
|
$0.00
|
$689,626.00
|
| Cost of Revenue |
$204,617.00 |
$30.95 B |
$28.36 B |
$55,060.00 |
$0.00 |
| Gross Profit |
-$204,617.00 |
-$28.24 B |
-$28.36 B |
-$55,060.00 |
$689,626.00 |
| Gross Profit Ratio |
0 |
-10.44 |
0 |
0 |
1 |
| Research and Development
Expenses |
$15.49 M
|
$23.12 M
|
$13.97 M
|
$9.51 M
|
$19.65 M
|
| General & Administrative
Expenses |
$7.43 M
|
$7.83 M
|
$4.64 M
|
$1.29 M
|
$3.83 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$7.43 M
|
$7.83 M
|
$4.64 M
|
$1.29 M
|
$3.83 M
|
| Other Expenses |
$0.00 |
$2.70 M |
-$9.53 M |
-$3.00 M |
$551,235.00 |
| Operating Expenses |
$22.92 M |
$30.95 M |
$18.61 M |
$10.80 M |
$23.48 M |
| Cost And Expenses |
$22.92 M |
$30.95 M |
$18.61 M |
$10.80 M |
$23.48 M |
| Interest Income |
$463,256.00 |
$253,323.00 |
$2,431.61 |
$2,440.90 |
$1,560.87 |
| Interest Expense |
$0.00 |
$253,323.00 |
$2.43 M |
$2.44 M |
$1.56 M |
| Depreciation &
Amortization |
$204,617.00
|
$121,749.00
|
$77,960.00
|
$55,060.00
|
$36,816.00
|
| EBITDA |
-$22.25 M
|
-$30.83 M
|
-$27.70 M
|
-$13.74 M
|
-$22.20 M
|
| EBITDA Ratio |
0 |
-0.01 |
0 |
0 |
-32.2 |
| Operating Income Ratio
|
0
|
-0.01
|
0
|
0
|
-32.31
|
| Total Other
Income/Expenses Net |
$463,246.00
|
$2.96 M
|
-$1.85 M
|
-$1.60 M
|
-$1.52 M
|
| Income Before Tax |
-$22.46 M |
-$27.99 M |
-$30.21 M |
-$16.24 M |
-$23.80 M |
| Income Before Tax Ratio
|
0
|
-0.01
|
0
|
0
|
-34.51
|
| Income Tax Expense |
$0.00 |
-$3.21 M |
-$7.10 M |
-$560,381.00 |
$2.11 M |
| Net Income |
-$22.46 M |
-$24.78 M |
-$23.11 M |
-$15.68 M |
-$25.91 M |
| Net Income Ratio |
0 |
-0.01 |
0 |
0 |
-37.58 |
| EPS |
-0.65 |
-0.74 |
-0.69 |
-0.47 |
-0.78 |
| EPS Diluted |
-0.65 |
-0.74 |
-0.69 |
-0.47 |
-0.78 |
| Weighted Average Shares
Out |
$34.36 M
|
$33.67 M
|
$33.48 M
|
$33.09 M
|
$33.09 M
|
| Weighted Average Shares
Out Diluted |
$34.36 M
|
$33.67 M
|
$33.48 M
|
$33.09 M
|
$33.09 M
|
| Link |
|
|
|
|
|
